Abbott granted 510(k) FDA clearance for two cataract surgery products
Click Here to Manage Email Alerts
The U.S. Food and Drug Administration has granted Abbott 510(k) clearance for its Cataract Operating System 3 and Liquid Optics Interface 12.
Both products are intended for use with the Catalys Precision Laser System, according to a company press release.
The Cataract Operating System 3 (cOS3) is designed to update the surgeon during the procedure with incision confirmation and custom modification options. It also yields high-resolution video streaming images of the patient’s eye.
The Liquid Optics Interface 12 has a smaller suction ring diameter than the current Liquid Optics Interface, helping to increase the number of patients eligible for laser cataract surgery. The interface is also meant to simplify the laser docking process for the surgeon, according to the release.